GEMSP
/ PolyNeuroS
- LARVOL DELTA
Home
Next
Prev
1 to 8
Of
8
Go to page
1
November 03, 2022
"holy shit i just got bank @good121326 @kasoutuukakun @seanmonkey @skippsforyou @AeroSamik @sherrykhan198 @drjamesgood @adamitis_ @618Zone @blockfarm8 @yongwang_6 @shadygemspro"
(@UnediJAYLX)
May 24, 2022
COVID-19 and zoonoses in Brazil: Environmental scan of one health preparedness and response.
(PubMed, One Health)
- "Brazil is considered an area of high risk for emergence of zoonoses mainly due to climate change, large-scale deforestation and urbanization, high wildlife biodiversity, wide dry frontier, and poor control of wild animals' traffic. Therefore, encouraging existing mechanisms for collaboration across sectors and disciplines, with the inclusion of vulnerable populations, is required for making a multisectoral OH approach successful in the country."
Journal • Infectious Disease • Novel Coronavirus Disease • Pulmonary Disease • Respiratory Diseases • Tuberculosis
May 25, 2021
"https://t.co/9kfdSuymsn @manitobahydro @ManitobaDental @CalmAir @ManitobaCUs @konicaminolta @TravelManitoba @gemspro Is that what you stand behind as sponsors ?https://t.co/4npUXjC1wS"
(@malone_j71)
July 05, 2020
GemSpot allows modeling of ligands in cryo-EM maps.
(PubMed, Nat Methods)
- No abstract available
Journal
November 25, 2017
"@ULGEMSPAEDS delighted to welcome our sponsors for our @paediatric_nephrology_study_day to CERC in UHL @ULHospitals @GSK @SMA_Nestle @novonordisk @sanofi @UL_GEMS"
(@ULGEMSPAEDS)
Clinical • Biosimilar
May 16, 2020
GemSpot: A Pipeline for Robust Modeling of Ligands into Cryo-EM Maps.
(PubMed, Structure)
- "In all cases, at least one identified pose produced both excellent interactions with the target and agreement with the map. GemSpot will be valuable for the robust identification of ligand poses and drug discovery efforts through cryo-EM."
Journal
March 16, 2019
Fatty acids and antioxidants in multiple sclerosis: Therapeutic role of GEMSP.
(PubMed, Curr Pharm Des)
- "In addition, in an open clinical trial in humans treated with GEMSP, in 72% of the cases, a positive evolution of the state of the MS patients treated with GMSP was observed. In this review a biochemical characterization of main constituents of GEMSP, which include fatty acids as oleic acid, linoleic acid or azelaic acid and the antioxidants alpha-tocopherol or ascorbic acid, will be provided in order to understand their proved therapeutic effects in MS."
Journal
December 03, 2019
"Gemspring Capital Makes Strategic Investment in Shrieve Chemical Company https://t.co/78tg04bZQi"
(@NewsFromBW)
1 to 8
Of
8
Go to page
1